Q2B 2022 SV | Quantum: Ahead of Ready | Dani Couger | Lockheed Martin

(17:6)

Q2B 2022 Tokyo | Welcome to Q2B Tokyo | Matt Johnson

(11:19)

Q2B 2022 SV | Quantum Computing \u0026 Pharma – the Perfect Match? | Michael Streif | BoehringerIngelheim

(15:39)

Q2B 2022 Tokyo | Accelerating the Journey Towards Quantum Advantage | Nir Minerbi

(10:28)

Q2B 2022 SV | Applications of Quantum Computing in Spectroscopy | Michael Marthaler | HQS

(15:38)

Q2B 2022 SV | Insights from a Mayo Clinic Innovator \u0026 the Mayo Clinic Innovation Exchange

(20:21)

Q2B 2022 SV | Azure Quantum and the Path to Scalable Quantum Computing | Wim van Dam | Microsoft

(25:47)

Q2B 2022 SV | Quantum Computing for PFAS Chemicals Remediation | Accenture \u0026 IonQ

(19:28)

Q2B 2022 SV | Quantum Computing at AWS | Richard Moulds \u0026 Oskar Painter | AWS

(23:40)

Q2B 2022 Tokyo | Overview of QunaSys R\u0026D + Ecosystem Development | Keita Kanno

(19:47)

Q2B 2022 Tokyo | How Startups Accelerate the Path to Quantum Advantage | Stefan Elrington

(21:18)

Q2B 2022 Tokyo | Quantum in the Enterprise | Hossein Sadeghi Esfahani

(18:51)

Q2B 2022 SV | Welcome to Q2B! | Matt Johnson | QC Ware

(6:58)

Q2B 2022 SV | How to Get the Most Out of Today’s Q. Devices w/ Amazon Braket | Dr. Daniela Becker

(19:34)

Q2B 2022 SV | Pharmaceuticals Panel

(39:43)

Q2B 2022 Tokyo | Keysight: At the heart of your quantum revolution | Gabe Lenetsky

(17:58)

Q2B 2022 SV | Q2B 2022 Global Quantum Computing Market Size and Forecast | Bob Sorensen | Hyperion

(20:11)